Efficacy and Safety of Stem Cell Therapy for T1DM: An Updated Systematic Review and Meta-Analysis.

Shi-Yi SunYun GaoGuan-Jian LiuYong-Kun LiWei GaoXing-Wu Ran

Published in: Journal of diabetes research (2020)

Stem cell therapy for T1DM may improve glycemic control and β cell function without increasing the risk of serious adverse events. Stem cell therapy may also have a short-term (3-6 months) effect on reducing insulin dosages.

Keyphrases

glycemic control
stem cells
type diabetes
blood glucose
weight loss
cell therapy
insulin resistance
bone marrow